Recurrent cerebral infarctions in polyarteritis nodosa with circulating antiphospholipid antibodies and mitral valve disease.

Abstract:

:A case of recurrent cerebral infarctions in a 42-year-old woman affected by polyarteritis nodosa and antiphospholipid syndrome is reported. Two-dimensional echocardiography revealed grossly thickened mitral valve leaflets, possibly related to the presence of antiphospholipid antibodies. Thus, an embolic source at mitral level is hypothesized.

journal_name

Lupus

journal_title

Lupus

authors

Morelli S,Perrone C,Paroli M

doi

10.1191/096120398678919642

subject

Has Abstract

pub_date

1998-01-01 00:00:00

pages

51-2

issue

1

eissn

0961-2033

issn

1477-0962

journal_volume

7

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Facial telangiectasia: an unusual manifestation of neonatal lupus erythematosus.

    abstract::Neonatal lupus erythematosus (NLE) is an uncommon condition usually associated with maternal anti-Ro autoantibodies. The cutaneous lesions of NLE are usually transient, disappearing about six months after birth, but telangiectasia is a rare complication of NLE which persists. Telangiectasias are small focal red macule...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311430701

    authors: Guinovart RM,Vicente A,Rovira C,Suñol M,González-Enseñat MA

    更新日期:2012-04-01 00:00:00

  • Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density.

    abstract::The purpose of this study was to evaluate the clinical characteristics of women with systemic lupus erythematosus (SLE) sent for a dual energy X-ray absorptiometry (DEXA) study, and to analyse the factors associated with a lower bone mineral density in these patients. Women with SLE who had a DEXA done between 1 Janua...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu1036oa

    authors: Pineau CA,Urowitz MB,Fortin PJ,Ibanez D,Gladman DD

    更新日期:2004-01-01 00:00:00

  • Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1.

    abstract::Renal involvement is one of the main complications of systemic lupus erythematosus, causing a significant impact on patients' morbidity and mortality. Renal biopsy is still the gold standard of diagnosis, but it has many limitations. In this sense, several recent studies aim to identify biomarkers that not only predic...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203319826695

    authors: Gasparin AA,Pamplona Bueno de Andrade N,Hax V,Tres GL,Veronese FV,Monticielo OA

    更新日期:2019-03-01 00:00:00

  • Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors.

    abstract::Recent studies have revealed new populations of T/B cells, including central/effector memory, follicular T cells and CXCR3+ or CXCR4+ B cells. In the present study, changes in these populations of CD4+ T cells were examined on the basis of the expression of CD62L, CCR7 and CXCR5 in patients with systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307085246

    authors: Watanabe T,Suzuki J,Mitsuo A,Nakano S,Tamayama Y,Katagiri A,Amano H,Morimoto S,Tokano Y,Takasaki Y

    更新日期:2008-01-01 00:00:00

  • Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.

    abstract:OBJECTIVE:The objective of this paper is to evaluate whether the different International Society of Nephrology/Renal Pathology Society (ISN/RPS) classes of proliferative lupus nephritis (LN) have a distinct baseline presentation, short-term response to immunosuppression (IS) and long-term prognosis. METHODS:Ninety-eig...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313514623

    authors: Vandepapelière J,Aydin S,Cosyns JP,Depresseux G,Jadoul M,Houssiau FA

    更新日期:2014-02-01 00:00:00

  • Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.

    abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/0961203304lu1067sr

    authors: Tam LS,Li EK,Wong CK,Lam CW,Szeto CC

    更新日期:2004-01-01 00:00:00

  • Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies.

    abstract::The presence of antibodies against the complex of prothrombin and phosphatidylserine (aPS/PT) more significantly correlates with manifestations of antiphospholipid syndrome (APS) and with the presence of lupus anticoagulants (LA) than antibodies against prothrombin bound to oxygenated polystyrene (aPT-A). To investiga...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307078680

    authors: Horita T,Ichikawa K,Kataoka H,Yasuda S,Atsumi T,Koike T

    更新日期:2007-01-01 00:00:00

  • Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists.

    abstract:INTRODUCTION:Identifying factors predicting adverse pregnancy outcomes involving systemic lupus erythematosus (SLE) is a research priority. The aims of this study were to investigate (a) the maternal and fetal outcomes of pregnant lupus patients and the factors associated with adverse pregnancy outcomes, and (b) the ef...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320944503

    authors: Janardana R,Haridas V,Priya V,Bhat V,Singh Y,Rao VK,Jois R,Srikantiah C,Pinto B,Shobha V

    更新日期:2020-10-01 00:00:00

  • Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.

    abstract:INTRODUCTION:Patients with systemic lupus erythematosus (SLE) with B-lymphocyte stimulator (BLyS) levels ≥ 2 ng/mL are at increased risk of flare. A regression analysis was undertaken to identify routine clinical measures that correlate with BLyS ≥ 2 ng/mL. Efficacy and safety of belimumab 10 mg/kg were examined in pat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315604909

    authors: Roth DA,Thompson A,Tang Y,Hammer AE,Molta CT,Gordon D

    更新日期:2016-04-01 00:00:00

  • Elucidation of the potential disease-promoting influence of IgM apoptotic cell-reactive antibodies in lupus.

    abstract::The undigested remnants of apoptosis are believed to stimulate the generation of autoantibodies in lupus. The biological properties of initiator, disease-specific IgM antibodies that specifically recognize apoptotic cells, readily detected in the sera of lupus patients, remain unclear. Apoptotic cell-reactive IgM mono...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315624023

    authors: Malik M,Arora P,Sachdeva R,Sharma L,Ramachandran VG,Pal R

    更新日期:2016-06-01 00:00:00

  • Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients.

    abstract::The aim of this study was to determine the frequency of anti-prolactin autoantibodies and the relationship among anti-prolactin autoantibodies, serum prolactin (PRL) levels and lupus activity in paediatric patients with systemic lupus erythematosus (SLE) using a transversal study. One-hundred and three consecutive pae...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120330101001107

    authors: Blanco-Favela F,Quintal MaG,Chavez-Rueda AK,Leaños-Miranda A,Berron-Peres R,Baca-Ruiz V,Lavalle-Montalvo C

    更新日期:2001-01-01 00:00:00

  • Diagnosis and risk stratification in patients with anti-RNP autoimmunity.

    abstract:INTRODUCTION:Anti-RNP autoantibodies occur either in mixed connective tissue disease (MCTD) (with a frequently favorable prognosis), or in systemic lupus erythematosus (SLE) cases with aggressive major organ disease. It is uncertain how to assess for the risk of severe disease in anti-RNP + patients. METHODS:Following...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315575586

    authors: Carpintero MF,Martinez L,Fernandez I,Romero AC,Mejia C,Zang YJ,Hoffman RW,Greidinger EL

    更新日期:2015-09-01 00:00:00

  • Antiphospholipid antibodies and myocardial infarction.

    abstract::In prospective studies, increased levels of cardiolipin-biding antibodies and autoantibodies to oxidized low-density lipoprotein (LDL) have been observed in patients with myocardial infarction (MI). These findings suggest that antiphospholipid antibodies may contribute to the development of MI. The 'oxidative-modifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700229

    authors: Vaarala O

    更新日期:1998-01-01 00:00:00

  • Association of TNFSF4 rs1234315, rs2205960 polymorphisms and systemic lupus erythematosus susceptibility: a meta-analysis.

    abstract:BACKGROUND:The aim of this study was to explore the association between tumor necrosis factor superfamily number 4 (TNFSF4) rs1234315, rs2205960 polymorphisms and systemic lupus erythematosus (SLE) susceptibility. METHODS:A meta-analysis was performed on the association between rs1234315 and rs2205960 polymorphisms an...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203319862610

    authors: Wang JM,Yuan ZC,Huang AF,Xu WD

    更新日期:2019-09-01 00:00:00

  • Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

    abstract:INTRODUCTION:High-mobility group box 1 protein (HMGB-1) has been implicated in the pathogenesis of lupus nephritis (LN). There is increased HMGB-1 expression in the kidneys and increased levels are observed in serum and urine of patients with LN. This study was performed to determine whether the increased urinary HMGB-...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316644331

    authors: Jog NR,Blanco I,Lee I,Putterman C,Caricchio R

    更新日期:2016-12-01 00:00:00

  • Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity.

    abstract:BACKGROUND:The main vitamin D source is exposure to ultraviolet radiation, which aggravates cutaneous lupus erythematosus (CLE). OBJECTIVES:The aims of this study were to identify variables associated with lower serum 25-hydroxyvitamin D [25(OH)D] levels in CLE patients and assess the effect of vitamin D restoration o...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314522338

    authors: Cutillas-Marco E,Marquina-Vila A,Grant WB,Vilata-Corell JJ,Morales-Suárez-Varela MM

    更新日期:2014-06-01 00:00:00

  • Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.

    abstract::Vaccines have undoubtedly brought overwhelming benefits to mankind and are considered safe and effective. Nevertheless, they can occasionally stimulate autoantibody production or even a recently defined syndrome known as autoimmune/inflammatory syndrome induced by adjuvants (ASIA). There is scarce data regarding autoi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311429817

    authors: Perdan-Pirkmajer K,Thallinger GG,Snoj N,Čučnik S,Žigon P,Kveder T,Logar D,Praprotnik S,Tomšič M,Sodin-Semrl S,Ambrožič A

    更新日期:2012-02-01 00:00:00

  • Lupus erythematosus proliferative glomerulonephritis in fetus.

    abstract::We report the case of a fetus with proliferative glomerulonephritis in the context of maternal systemic lupus erythematosus (SLE). The pattern of the renal lesions correspond to the class III of revisited WHO classification of glomerulonephritis in SLE. Amniotic fluid analysis showed a high level of albumin and the pr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2045cr

    authors: Daïkha-Dahmane F,Bault JP,Molina-Gomes D,Hillion D,Ville Y

    更新日期:2005-01-01 00:00:00

  • Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.

    abstract::HIN200 is a human IFN-inducible gene and homologous to murine IFI202 gene, which was identified as a candidate gene for SLE susceptibility in lupus mouse model. We determined these gene expressions in leukocytes from 20 SLE patients and 10 healthy controls and in renal biopsies from 29 SLE patients and 15 kidney donor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309106699

    authors: Kimkong I,Avihingsanon Y,Hirankarn N

    更新日期:2009-10-01 00:00:00

  • Cardio-pulmonary involvement in juvenile systemic lupus erythematosus.

    abstract::Cardio-pulmonary manifestations of systemic lupus erythematosus (SLE) are well recognized in adults. We report the occurrence of clinically significant cardio-pulmonary disease in a cohort of predominantly Caucasian children with SLE. All children with SLE attending the Royal Liverpool Children's NHS Trust between 199...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2073oa

    authors: Beresford MW,Cleary AG,Sills JA,Couriel J,Davidson JE

    更新日期:2005-01-01 00:00:00

  • Maternal deaths in women with lupus nephritis: a review of published evidence.

    abstract:BACKGROUND AND OBJECTIVES:Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to pe...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311434939

    authors: Ritchie J,Smyth A,Tower C,Helbert M,Venning M,Garovic V

    更新日期:2012-04-01 00:00:00

  • Does SLE widen or narrow race/ethnic disparities in the risk of five co-morbid conditions? Evidence from a community-based outpatient care system.

    abstract:OBJECTIVE:The heterogeneous spectrum of systemic lupus erythematosus (SLE) often presents with secondary complications such as cardiovascular disease (CVD), infections and neoplasms. Our study assessed whether the presence of SLE independently increases or reduces the disparities, accounting for the already higher risk...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319884646

    authors: Falasinnu T,Chaichian Y,Li J,Chung S,Waitzfelder BE,Fortmann SP,Palaniappan L,Simard JF

    更新日期:2019-12-01 00:00:00

  • Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity.

    abstract::Systemic lupus erythematosus (SLE) is a severe chronic inflammatory autoimmune connective tissue disease. Despite major efforts, SLE remains a poorly understood disease with unpredictable course, unknown etiology and complex pathogenesis. Apoptosis combined with deficiency in clearing apoptotic cells is an important e...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316669240

    authors: Delfani P,Sturfelt G,Gullstrand B,Carlsson A,Kassandra M,Borrebaeck CA,Bengtsson AA,Wingren C

    更新日期:2017-04-01 00:00:00

  • Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.

    abstract::Objectives The aim of this study was to study the relationship between immunosuppressive drug treatment and survival in patients with systemic lupus erythematosus (SLE). Methods Patients who fulfilled four or more American College of Rheumatology criteria for SLE were followed longitudinally. Clinical characteristics,...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317739129

    authors: Mok CC,Tse SM,Chan KL,Ho LY

    更新日期:2018-04-01 00:00:00

  • Pulmonary arterial hypertension in SLE: what do we know?

    abstract::Pulmonary hypertension (PH) can occur at any time during the course of systemic lupus erythematosus (SLE), and can be independent of lupus disease activity in other systems. The pathogenesis of PH in SLE can be multifactorial, but pulmonary arterial hypertension (PAH) is the commonest cause of PH in SLE. The internati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313505010

    authors: Prabu A,Gordon C

    更新日期:2013-10-01 00:00:00

  • T-regulatory cells in systemic lupus erythematosus.

    abstract::Thymus-derived CD4(+)CD25(high)Foxp3(+) T-regulatory cells (Tregs) have an important role in the mechanisms of peripheral immune tolerance and in the prevention of pathogenic autoimmunity through the suppression of proliferation and production of pro-inflammatory cytokines in effector immune cells. Some studies have s...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308090028

    authors: La Cava A

    更新日期:2008-05-01 00:00:00

  • The SLICC/ACR damage index: progress report and experience in the field.

    abstract::The SLICC/ACR damage index for SLE was developed to assess accumulated damage since the onset of the disease. The damage includes non-reversible changes in organs and systems affected by the disease process itself, its therapy, or inter-current illness. This paper describes the development of the damage index, its val...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399680411335

    authors: Gladman DD,Urowitz MB

    更新日期:1999-01-01 00:00:00

  • Vaccination and systemic lupus erythematosus: the bidirectional dilemmas.

    abstract::Vaccination has been perhaps the most important achievement in medicine of the last century. A hoard of infectious diseases that used to claim the lives of many, especially children, have been prevented and some even eradicated. However, it is possible that within this gift there is hidden a 'Trojan Horse'. During the...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301673085478

    authors: Aron-Maor A,Shoenfeld Y

    更新日期:2001-01-01 00:00:00

  • Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response.

    abstract::Immune-mediated sensorineural hearing loss may complicate systemic autoimmune diseases. We have previously reported the presence of antibodies directed against inner ear antigens in patients with Cogan syndrome, a disease characterized by sudden hearing loss and interstitial keratitis. Such autoantibodies cross-react ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316682099

    authors: Bason C,Pagnini I,Brucato A,Maestroni S,Puccetti A,Lunardi C,Cimaz R

    更新日期:2017-07-01 00:00:00

  • Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand.

    abstract:Background:Strongyloidiasis can be fatal in systemic lupus erythematosus (SLE) patients, but few epidemiological studies have investigated the burden of this tropical disease among the SLE population. This study aimed to assess the prevalence and associated factors of strongyloidiasis among SLE patients in Southern Tha...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320911091

    authors: Juthong S,Geater AF,Dekumyoy P,Hortiwakul T,Siripaitoon B,Aiewruengsurat D,Thongbun N

    更新日期:2020-05-01 00:00:00